je.st
news
The Outlook For Biotech M&A
2015-09-19 00:23:08| Biotech - Topix.net
Merger and acquisition activity in the pharmaceutical and biotech sectors has been robust this year and is approaching levels not seen in a decade. There are myriad reasons to believe this trend will continue including low financing rates and the need to replace revenues from blockbusters losing patent protection in the next few years.
Tags: ma
outlook
biotech
Category:Biotechnology and Pharmaceuticals